Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 140

Results For "Act"

7963 News Found

Agenus launches landmark global Phase 3 trial in hard-to-treat colorectal cancer
Clinical Trials | April 03, 2026

Agenus launches landmark global Phase 3 trial in hard-to-treat colorectal cancer

The study targets patients with refractory, unresectable microsatellite-stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC)


ZEISS India strengthens portfolio with the launch of ZEISS ClearMind lenses
News | April 03, 2026

ZEISS India strengthens portfolio with the launch of ZEISS ClearMind lenses

Developed for today’s fast-paced, visually demanding lifestyles, the lenses are built on ZEISS NeurOptix technology


Sahyadri Hospital brings first non-surgical treatment for severe knee pain to Maharashtra
Hospitals | April 03, 2026

Sahyadri Hospital brings first non-surgical treatment for severe knee pain to Maharashtra

Low-dose radiotherapy offers immediate pain relief, quicker recovery, and better movement through a non-invasive procedure


Mitsui Chemicals unveils world’s first device for continuous bile excretion in lab-grown liver cells
Medical Device | April 03, 2026

Mitsui Chemicals unveils world’s first device for continuous bile excretion in lab-grown liver cells

The innovation leverages Mitsui Chemicals’ oxygen-permeable InnoCell cell culture plate to efficiently collect bile while reducing stress on liver cells


EMA moves to cut animal testing with “virtual control groups” in preclinical research
Policy | April 03, 2026

EMA moves to cut animal testing with “virtual control groups” in preclinical research

The approach, which could significantly reduce the number of rats used in certain dose-range finding studies


Cardinal Health boosts production of cutting-edge cancer therapy ingredient
News | April 03, 2026

Cardinal Health boosts production of cutting-edge cancer therapy ingredient

Ac-225, an alpha-emitting radionuclide, can be paired with molecules designed to selectively target cancer cells.


Marksans Pharma receives USFDA approval for Benzonatate capsules
Drug Approval | April 02, 2026

Marksans Pharma receives USFDA approval for Benzonatate capsules

Benzonatate is a non-narcotic antitussive that numbs stretch receptors in the respiratory tract


Saharsh Davuluri takes over as CEO & MD of Neuland  Laboratories
Appointment | April 02, 2026

Saharsh Davuluri takes over as CEO & MD of Neuland Laboratories

18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist


Middle East disruption hits thousands of global clinical trials, Phesi warns
Clinical Trials | April 02, 2026

Middle East disruption hits thousands of global clinical trials, Phesi warns

The impact on Phase III trials is particularly significant, as these later-stage studies involve larger, committed patient populations and represent years of investment


Alembic Pharmaceuticals partners with Enthral.ai for learning and training management of its 9000+ learners
News | April 02, 2026

Alembic Pharmaceuticals partners with Enthral.ai for learning and training management of its 9000+ learners

Enthral.ai’s platform integrates AI-driven capabilities with compliance-first architecture, enabling automated training workflows